MoneyWorks4Me

Lyka Labs informs about issue of duplicate certificate

25 Jan 2023 Evaluate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, Lyka Labs has informed that the Company has given effect to the issuance of duplicate share certificate in lieu of lost / misplaced share certificate.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1746.20
Dr. Reddys Labs. 1232.75
Cipla 1331.15
Lupin 1949.50
Zydus Lifesciences 1117.55
View more..